Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lyme disease probe leads Biocode's new range

This article was originally published in Clinica

Executive Summary

Prob-Lyme, a DNA amplification test for early detection of Borrelia burgdorferi, has been launched by Biocide (Belgium). The kit, comprising three probes, is claimed to be extremely sensitive and specific in detecting the Lyme disease-causative organism in skin, blood, synovial fluid and urine samples. Results are available within two hours. In addition to disease detection, the test can be used to monitor drug treatment.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087441

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel